Antiviral Prevention of Sepsis Induced Cytomegalovirus Reactivation in Immunocompetent Mice

INTRODUCTION: Immunocompetent patients can reactivate latent cytomegalovirus (CMV) during critical illness and reactivation is associated with significantly worse outcomes. Prior to clinical trials in humans to prove causality, we sought to determine an optimal antiviral treatment strategy. METHODS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Forster, Meghan R., Trgovcich, Joanne, Zimmerman, Peter, Chang, Alexander, Miller, Cortland, Klenerman, Paul, Cook, Charles H.
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2830346/
https://ncbi.nlm.nih.gov/pubmed/20004216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2009.12.004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars